Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Social Psychiatry and Psychiatric Epidemiology
Published in: Social Psychiatry and Psychiatric Epidemiology 11/2010

01-11-2010 | Original Paper

An expert panel assessment of comprehensive medication reviews for clients of community mental health teams

Authors: Natasa Gisev, J. Simon Bell, Claire L. O’Reilly, Alan Rosen, Timothy F. Chen

Published in: Social Psychiatry and Psychiatric Epidemiology | Issue 11/2010

Login to get access

Abstract

Background

Few studies have investigated strategies to identify and resolve drug-related problems among clients of community mental health teams (CMHTs).

Objective

The objective of this study was to evaluate the clinical impact and appropriateness of comprehensive medication reviews for clients of CMHTs.

Methods

Trained pharmacists conducted interviews (30–45 min each) with clients of CMHTs to identify actual and potential drug-related problems. The pharmacists prepared medication review reports that detailed their findings and recommendations to optimize drug therapy. An expert panel comprising a psychiatrist, general medical practitioner, mental health pharmacist and medication review pharmacist evaluated reviews for 48 clients of 5 CMHTs. Panelists independently assessed review findings, review recommendations, likelihood of recommendation implementation and the overall expected clinical impact.

Results

Two hundred and nine medication review findings and 208 medication review recommendations were evaluated. Panelists agreed with 76% of findings and considered that 81% of recommendations were appropriate. Collectively, 69% of recommendations were considered likely to be implemented. Thirty-seven (77%) reviews were deemed potentially to have a positive clinical impact. The agreement between panelists was statistically significant (P < 0.01) for the assessment of the findings, recommendations and likelihood of recommendation implementation.

Conclusions

Pharmacists’ findings and recommendations to optimize drug therapy were considered appropriate and likely to result in improved clinical outcomes. Comprehensive medication reviews may be a valuable strategy to identify and resolve drug-related problems among clients of CMHTs.
Literature
1.
2.
Barnes TRE, Paton C, Cavanagh M-R, Hancock E, Taylor DM (2007) A UK audit of screening for the metabolic side effects of antipsychotics in community patients. Schizophr Bull 33:1397–1403CrossRefPubMed
3.
Bates DW, Cullen DJ, Laird N et al (1995) Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA 274:29–34CrossRefPubMed
4.
Bell JS, Rosen A, Aslani P, Whitehead P, Chen TF (2007) Developing the role of pharmacists as members of community mental health teams: perspectives of pharmacists and mental health professionals. Res Social Adm Pharm 3:392–409PubMed
5.
Bell JS, Whitehead P, Aslani P, McLachlan AJ, Chen TF (2006) Drug-related problems in the community setting: pharmacists’ findings and recommendations for people with mental illnesses. Clin Drug Investig 26:415–425CrossRefPubMed
6.
Bell JS, Whitehead P, Aslani P, Sacker S, Chen TF (2006) Design and implementation of an educational partnership between community pharmacists and consumer educators in mental health care. Am J Pharm Educ 70:28PubMed
7.
Bell S, McLachlan AJ, Aslani P, Whitehead P, Chen TF (2005) Community pharmacy services to optimise the use of medications for mental illness: a systematic review. Aust New Zealand Health Policy 2:29CrossRefPubMed
8.
Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Lawrence Erlbaum, New Jersey, pp 75–83
9.
Ellitt GR, Brien JA, Aslani P, Chen TF (2009) Quality patient care and pharmacists' role in its continuity—a systematic review. Ann Pharmacother 43:677–691
10.
Ewan MA, Greene RJ (2001) Evaluation of mental health care interventions made by three community pharmacists—a pilot study. Int J Pharm Pract 9:225–234
11.
Gilbert AL, Roughead EE, Beilby J, Mott K, Barratt JD (2002) Collaborative medication management services: improving patient care. Med J Aust 177:189–192PubMed
12.
Gisev N, Bell JS, McLachlan AJ, Chetty M, Chen TF (2006) Psychiatric drug use among patients of a community mental health service: patterns and implications. Dis Manag Health Outcomes 14:369–376CrossRef
13.
Harris D, Anderson C (2003) Interventions by community pharmacists for older people with mental health problems: are they appropriate? [abstract]. Int J Pharm Pract 11:R56
14.
Hawksworth GM, Corlett AJ, Wright DJ, Chrystyn H (1999) Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol 47:695–700CrossRefPubMed
15.
Heiman GW (2001) Understanding research methods and statistics: an integrated introduction for psychology, 2nd edn. Houghton Mifflin, Boston, pp 257–262
16.
Holland R, Lenaghan E, Harvey I et al (2005) Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. Br Med J 330:292–298CrossRef
17.
Institute of Medicine (2000) To err is human: building a safer health system
18.
Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL (2006) Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med 166:955–964CrossRefPubMed
19.
Krass I, Smith C (2000) Impact of medication regimen reviews performed by community pharmacists for ambulatory patients with general medical practitioners. Int J Pharm Pract 8:111–120
20.
Krska J, Avery AJ, Community Pharmacy Medicines Management Project Evaluation Team (2008) Evaluation of medication reviews conducted by community pharmacists: a quantitative analysis of documented issues and recommendations. Br J Clin Pharmacol 65:386–395CrossRefPubMed
21.
Maidment ID, Lelliott P, Paton C (2006) Medication errors in mental healthcare: a systematic review. Qual Saf Health Care 15:409–413CrossRefPubMed
22.
Mann K, Rothschild JM, Keohane CA, Chu JA, Bates DW (2008) Adverse drug events and medication errors in psychiatry: methodological issues regarding identification and classification. World J Biol Psychiatry 9:24–33CrossRefPubMed
23.
Mannheimer B, Ulfvarson J, Eklof S et al (2006) Drug-related problems and pharmacotherapeutic advisory intervention at a medicine clinic. Eur J Clin Pharmacol 62:1075–1081CrossRefPubMed
24.
Meagher D, Moran M (2003) Sub-optimal prescribing in an adult community mental health service: prevalence and determinants. Psychiatr Bull 27:266–270CrossRef
25.
Mitchell AJ (2007) Adherence behaviour with psychotropic medication is a form of self-medication. Med Hypotheses 68:12–21CrossRefPubMed
26.
Morcos S, Francis S-A, Duggan C (2002) Where are the weakest links? A descriptive study of discrepancies in prescribing between primary and secondary sectors of mental health service provision. Psychiatr Bull 26:371–374CrossRef
27.
Nathan A, Goodyer L, Lovejoy A, Rashid A (1999) Brown bag medication reviews as a means of optimizing patients’ use of medication and identifying potential clinical problems. Fam Pract 16:278–282CrossRefPubMed
28.
Nguyen A, Yu K, Shakib S et al (2007) Classification of findings in the home medicines reviews of post-discharge patients at risk of medication misadventure. J Pharm Pract Res 37:111–114
29.
Nishtala PS, McLachlan AJ, Bell JS, Chen TF (2008) Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. Am J Geriatr Psychiatry 16:621–632CrossRefPubMed
30.
Pirkis J, Burgess P, Coombs T et al (2005) Routine measurement of outcomes in Australia’s public sector mental health services. Aust New Zealand Health Policy 2:8CrossRefPubMed
31.
Pirmohamed M, James S, Meakin S et al (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. Br Med J 329:15–19CrossRef
32.
Roberts MS, Stokes JA, King MA et al (2001) Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol 51:257–265CrossRefPubMed
33.
34.
Rosen A, Callaly T (2005) Interdisciplinary teamwork and leadership: issues for psychiatrists. Australas Psychiatry 13:234–240PubMed
35.
Rothschild JM, Mann K, Keohane CA et al (2007) Medication safety in a psychiatric hospital. Gen Hosp Psychiatry 29:156–162CrossRefPubMed
36.
Roughead EE, Barratt JD, Gilbert AL (2004) Medication-related problems commonly occurring in an Australian community setting. Pharmacoepidemiol Drug Saf 13:83–87CrossRefPubMed
37.
Roughead EE, Barratt JD, Ramsay E et al (2009) The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study. Circ Heart Fail 2:424–428
38.
Ruschena D, Mullen PE, Burgess P et al (1998) Sudden death in psychiatric patients. Br J Psychiatry 172:331–336CrossRefPubMed
39.
Sheskin DJ (2007) Handbook of parametric and nonparametric statistical procedures, 4th edn. Chapman & Hall/CRC, Boca Raton, pp 1387–1401
40.
Siegal S, Castellan NJ Jr (1988) Nonparametric statistics for the behavioural sciences, 2nd edn. McGraw-Hill, New York, pp 262–272
41.
Smith MA, Simpson JM, Benrimoj SI (2002) General practitioner acceptance of medication review in Sydney nursing homes. J Pharm Pract Res 32:227–231
42.
Soendergaard B, Kirkeby B, Dinsen C, Herborg H, Staehr P (2006) Drug-related problems in general practice: results from a development project in Denmark. Pharm World Sci 28:61–64CrossRefPubMed
43.
Sorensen L, Stokes JA, Purdie DM et al (2004) Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol 58:648–664CrossRefPubMed
44.
Spinewine A, Schmader KE, Barber N et al (2007) Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 370:173–184CrossRefPubMed
45.
Tranulis C, Skalli L, Lalonde P, Nicole L, Stip E (2008) Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature. Drug Saf 31:7–20CrossRefPubMed
46.
WHO Collaborating Centre for Drug Statistics Methodology (2008) The anatomical therapeutic chemical classification system. WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health, Oslo
47.
Metadata
Title
An expert panel assessment of comprehensive medication reviews for clients of community mental health teams
Authors
Natasa Gisev
J. Simon Bell
Claire L. O’Reilly
Alan Rosen
Timothy F. Chen
Publication date
01-11-2010
Publisher
Springer-Verlag
Published in
Social Psychiatry and Psychiatric Epidemiology / Issue 11/2010
Print ISSN: 0933-7954
Electronic ISSN: 1433-9285
DOI
https://doi.org/10.1007/s00127-009-0148-8

Other articles of this Issue 11/2010

Social Psychiatry and Psychiatric Epidemiology 11/2010 Go to the issue

Original Paper

Psychiatric staff perceptions of patient attachments: a pilot study to investigate differences in and predictors of psychiatric staff perceptions of patient attachments

Original Paper

The relationship of multiple aspects of stigma and personal contact with someone hospitalized for mental illness, in a nationally representative sample

Original Paper

Parents’ mental health and children’s cognitive and social development

Original Paper

Who are the restrained and secluded patients: a 15-year nationwide study

Original Paper

Association between bullying at work and mental disorders: gender differences in the Italian people

Original Paper

A prospective study of substance use and housing stability in a homeless population